MedTrace Logo

High-protein Oral Nutrition With HMB for Active CD Patients With Sarcopenia

NCT07171593 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-09-12

No results posted yet for this study

Summary

The efficacy of B-hydroxy-β-methybutyrate in sarcopenia

Conditions

  • Handgrip Strength

Interventions

DIETARY_SUPPLEMENT

HMB

EEN+HMB

Sponsors & Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Kang Chao · The Sixth Affiliated Hospital, Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-04
Primary Completion
2024-05-22
Completion
2026-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07171593 on ClinicalTrials.gov